Search Results

Filter
  • 1-10 of  55,562 results for ""CYCLOSPORINE""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).

  • Authors : Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan. .; Sako M

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects ; Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/diagnosis ; Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/drug therapy

  • Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Apr; Vol. 28 (4), pp. 337-348. Date of Electronic Publication: 2023 Nov 27.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7799

Record details

×
Academic Journal

Rapidly Dissolving Trans-scleral Microneedles for Intraocular Delivery of Cyclosporine A.

  • Authors : Alrbyawi H; Department of Drug Discovery and Development, Auburn University, Auburn, Alabama, USA.; Pharmaceutics and Pharmaceutical Technology Department, College of Pharmacy, Taibah University, Medina, Saudi Arabia.

Subjects: Cyclosporine* ; Eye*; Animals

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Feb 01; Vol. 25 (2), pp. 28. Date of Electronic Publication: 2024 Feb 01.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

×
Academic Journal

Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.

  • Authors : Guareschi F; ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.; Del Favero E

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; COVID-19*; Humans

  • Source: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Feb 01; Vol. 193, pp. 106673. Date of Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Nsp1 facilitates SARS-CoV-2 replication through calcineurin-NFAT signaling.

  • Authors : Lui W-Y; School of Biomedical Sciences, The University of Hong Kong, Pokfulam, Hong Kong.; Ong CP

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; COVID-19*; Humans

  • Source: MBio [mBio] 2024 Apr 10; Vol. 15 (4), pp. e0039224. Date of Electronic Publication: 2024 Feb 27.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Exploring the Effects of Cyclosporin A to Isocyclosporin A Rearrangement on Ion Mobility Separation.

  • Authors : Mácha H; Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 142 00, Czech Republic.; Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. listopadu 12, Olomouc 771 46, Czech Republic.

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/chemistry ; Peptides*/Peptides*/Peptides*/chemistry ; Cyclosporins*

  • Source: Analytical chemistry [Anal Chem] 2024 Mar 12; Vol. 96 (10), pp. 4163-4170. Date of Electronic Publication: 2024 Mar 02.Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370536 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study.

  • Authors : Scheinberg P; Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo, Brazil. Electronic address: .; Finelli C

Subjects: Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Pyrazoles*/Pyrazoles*/Pyrazoles*/therapeutic use

  • Source: The Lancet. Haematology [Lancet Haematol] 2024 Mar; Vol. 11 (3), pp. e206-e215. Date of Electronic Publication: 2024 Feb 06.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Consideration of ATG-free therapy with eltrombopag and cyclosporine for severe aplastic anaemia.

  • Authors : Groarke EM; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Pyrazoles*

  • Source: The Lancet. Haematology [Lancet Haematol] 2024 Mar; Vol. 11 (3), pp. e173-e174. Date of Electronic Publication: 2024 Feb 06.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques.

Subjects: Sirolimus*/Sirolimus*/Sirolimus*/pharmacology ; Sirolimus*/Sirolimus*/Sirolimus*/therapeutic use ; Sirolimus*/Sirolimus*/Sirolimus*/metabolism

  • Source: Gene therapy [Gene Ther] 2024 Mar; Vol. 31 (3-4), pp. 128-143. Date of Electronic Publication: 2023 Oct 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-psoriatic characteristics of ROCEN (topical Arthrocen) in comparison with Cyclosporine A in a murine model.

  • Authors : Goudarzi R; Division of Research and Development, Pharmin USA, LLC, San Jose, CA, USA.; Min-Ho Kim

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy; Animals

  • Source: BMC complementary medicine and therapies [BMC Complement Med Ther] 2024 Feb 24; Vol. 24 (1), pp. 100. Date of Electronic Publication: 2024 Feb 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101761232 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-7671

Record details

×
Academic Journal

High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification.

  • Authors : Klont F; Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. .; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.

Subjects: Excipients*/Excipients*/Excipients*/chemistry ; Cyclosporine*; Humans

  • Source: The Analyst [Analyst] 2024 Feb 12; Vol. 149 (4), pp. 1061-1067. Date of Electronic Publication: 2024 Feb 12.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 0372652 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  55,562 results for ""CYCLOSPORINE""